Report Detail
Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status and Forecast 2021-2027
- RnM4335202 |
- 20 July, 2021 |
- Global |
- 166 Pages |
- GRD Survey |
- Pharma & Healthcare
This report provides a comprehensive analysis of current global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to this survey, the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Control Hyperphosphatemia
Maintain Blood Calcium Levels
Segmented by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Other
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Spectrum
Shield
Sanofi Genzyme
OPKO
Novadiol
Japan Tobacco Company
Fresenius
Daiichi-Sankyo
Astellas
Ardelyx
Amgen
Akebia
Abbvie
Abbott
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status and Forecast (2016-2027)
- 1.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Supply by Company
- 2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Company
- 2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Company
- 2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Company
- 2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Production Location and Sales Area of Main Manufacturers
- 2.5 Trend of Concentration Rate
3 Global and Regional Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status by Type
- 3.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Type Introduction
- 3.1.1 Control Hyperphosphatemia
- 3.1.2 Maintain Blood Calcium Levels
- 3.1.3 Control PTH Level
- 3.1.4 Correct Acidosis
- 3.1.5 Other
- 3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Type
- 3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Type (2016-2021)
- 3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Type (2016-2021)
- 3.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Type (2016-2021)
- 3.3 North America: by Type
- 3.4 Europe: by Type
- 3.5 Asia Pacific: by Type
- 3.6 Central & South America: by Type
- 3.7 Middle East & Africa: by Type
4 Global and Regional Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status by Application
- 4.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
- 4.1.1 Hospital Pharmacies
- 4.1.2 Retail Pharmacies
- 4.1.3 Online Pharmacies
- 4.1.4 Drug Stores
- 4.1.5 Other
- 4.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Application
- 4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Application (2016-2021)
- 4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Application (2016-2021)
- 4.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price by Application (2016-2021)
- 4.3 North America: by Application
- 4.4 Europe: by Application
- 4.5 Asia Pacific: by Application
- 4.6 Central & South America: by Application
- 4.7 Middle East & Africa: by Application
5 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status by Region
- 5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Region
- 5.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Region
- 5.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Region
- 5.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 5.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 5.4 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 5.5 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 5.6 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
6 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 6.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
- 6.1.1 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
- 6.1.2 North America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
- 7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
- 7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 8.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
- 8.1.1 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
- 8.1.2 Asia Pacific Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 9.1 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
- 9.1.1 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
- 9.1.2 Central & South America Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status
- 10.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market by Country
- 10.1.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume by Country (2016-2021)
- 10.1.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value by Country (2016-2021)
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
- 11.1 Supply Chain Analysis
- 11.2 Production Process Chart Analysis
- 11.3 Raw Materials and Key Suppliers Analysis
- 11.3.1 Raw Materials Introduction
- 11.3.2 Raw Materials Key Suppliers List
- 11.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Cost Analysis
- 11.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channel and Distributors Analysis
- 11.5.1 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Channel
- 11.5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
- 11.6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Downstream Major Buyers
12 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Type and by Application
- 12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume and Sales Value Forecast (2022-2027)
- 12.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Type
- 12.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume Forecast by Type
- 12.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value Forecast by Type
- 12.2.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Type
- 12.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Application
- 12.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume Forecast by Application
- 12.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value Forecast by Application
- 12.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Price Forecast by Application
13 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Region/Country
- 13.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Forecast by Region (2022-2027)
- 13.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume Forecast by Region (2022-2027)
- 13.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Value Forecast by Region (2022-2027)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 Vifor
- 14.1.1 Company Information
- 14.1.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.1.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.1.4 SWOT Analysis
- 14.2 Takeda
- 14.2.1 Company Information
- 14.2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.2.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.2.4 SWOT Analysis
- 14.3 Spectrum
- 14.3.1 Company Information
- 14.3.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.3.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.3.4 SWOT Analysis
- 14.4 Shield
- 14.4.1 Company Information
- 14.4.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.4.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.4.4 SWOT Analysis
- 14.5 Sanofi Genzyme
- 14.5.1 Company Information
- 14.5.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.5.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.5.4 SWOT Analysis
- 14.6 OPKO
- 14.6.1 Company Information
- 14.6.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.6.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.6.4 SWOT Analysis
- 14.7 Novadiol
- 14.7.1 Company Information
- 14.7.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.7.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.7.4 SWOT Analysis
- 14.8 Japan Tobacco Company
- 14.8.1 Company Information
- 14.8.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.8.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.8.4 SWOT Analysis
- 14.9 Fresenius
- 14.9.1 Company Information
- 14.9.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.9.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.9.4 SWOT Analysis
- 14.10 Daiichi-Sankyo
- 14.10.1 Company Information
- 14.10.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Introduction
- 14.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
- 14.10.4 SWOT Analysis
- 14.11 Astellas
- 14.12 Ardelyx
- 14.13 Amgen
- 14.14 Akebia
- 14.15 Abbvie
- 14.16 Abbott
15 Conclusion
16 Methodology
Summary:
Get latest Market Research Reports on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD). Industry analysis & Market Report on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is a syndicated market report, published as Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
